CURE — Biocure Technology Balance Sheet
0.000.00%
Last trade - 00:00
EnergyHighly SpeculativeMicro Cap
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.109 | 0.132 | 0.047 | 0.159 | 0.038 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.033 | 0.089 | 0.071 | 1.9 | 0.022 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.182 | 0.234 | 0.136 | 2.13 | 0.118 |
Net Property, Plant And Equipment | 0.165 | 0.107 | 0.086 | 0.008 | 0 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 3.62 | 4.58 | 4.55 | 4.15 | 2.08 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.91 | 2.21 | 3.94 | 3.75 | 4.41 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 2.72 | 4.87 | 6.55 | 4.69 | 4.06 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.901 | -0.291 | -2 | -0.533 | -1.98 |
Total Liabilities & Shareholders' Equity | 3.62 | 4.58 | 4.55 | 4.15 | 2.08 |
Total Common Shares Outstanding |